Provided by Tiger Trade Technology Pte. Ltd.

Tempus AI

76.63
+0.13000.17%
Post-market: 76.750.1200+0.16%19:59 EDT
Volume:5.69M
Turnover:440.74M
Market Cap:13.91B
PE:-53.45
High:80.31
Open:77.36
Low:75.80
Close:76.50
52wk High:104.32
52wk Low:40.77
Shares:181.56M
Float Shares:115.00M
Volume Ratio:0.87
T/O Rate:4.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4337
EPS(LYR):-1.4100
ROE:-67.44%
ROA:-8.55%
PB:31.27
PE(LYR):-54.35

Loading ...

More Cracks Appear Inside The AI Bond Market!

AI Industry Frontlines
·
Jul 28

Anthropic Considers Mandatory Stock Trading Plan For All Employees Ahead Of IPO, Breaking Industry Norms

Hong Kong & US IPO Tracker
·
Jul 27

AI Sector Under Massive Valuation Reset: Market Abandons Blind Capex Hype, Focuses On Cash Flow & ROI

Bellwether Stocks Movement
·
Jul 27

Movement Alert|Tempus AI Falls 5.26% in Regular Trading, Sector Weakness and Acquisition Uncertainty Weigh Ahead of Earnings

Market Focus
·
Jul 24

Earning Preview: Tempus AI this quarter’s revenue is expected to increase by 27.92%, and institutional views are bullish

Earnings Agent
·
Jul 24

SAP CFO: Generic Chatbots Bring Little Profit; Enterprise Process AI Is True Growth Driver

Analyst Calls
·
Jul 24

Movement Alert|Tempus AI Rises 6.43% in Pre-Market Trading, Stock Recovers as Analyst Endorses Personalis Acquisition Valuation

Market Focus
·
Jul 23

Movement Alert|Tempus AI Rises 5.54% Overnight, Recovering From Post-Acquisition Dip as Analyst Validates Deal Valuation

Market Focus
·
Jul 23

Tempus AI announces national launch of OneOme pharmacogenomics testing

TIPRANKS
·
Jul 22

Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM), Immunome (IMNM) and Incyte (INCY)

TIPRANKS
·
Jul 22

Analysts Are Neutral on These Healthcare Stocks: Cencora (COR), Avita Medical (RCEL)

TIPRANKS
·
Jul 22

Tempus AI (TEM) Stock May Trade Below Fair Value Despite Mixed Checks

Simply Wall St.
·
Jul 22

Tempus AI: Buy Rating Reaffirmed as Personalis Deal Strengthens MRD Position; $75 Price Target Maintained

TIPRANKS
·
Jul 22

Tempus AI Makes Billion-Dollar Bet on the Future of Cancer Monitoring

Benzinga_recent_news
·
Jul 22

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Tempus AI, Inc. Class A (TEM) and 4D Molecular Therapeutics (FDMT)

TIPRANKS
·
Jul 21

AI Bull Run Hits A Crossroads! Wall Street Erupts In Rare Bull-Bear Showdown

AI Industry Frontlines
·
Jul 21

Personalis Acquisition Price Warranted by Growth Prospects, Needham Says

MT Newswires Live
·
Jul 21

Morgan Stanley sees strategic logic in Personalis deal despite financial hurdles

TIPRANKS
·
Jul 21

AI Daily: Tempus AI to acquire Personalis at enterprise value of $1.5B

TIPRANKS
·
Jul 21

Top Midday Decliners

MT Newswires Live
·
Jul 21